Close

JMP Securities Downgrades Adamas Pharmaceuticals (ADMS) to Market Perform, Following Acquisition Oct 11, 2021 03:41PM
Adamas to Present at Upcoming June Conferences May 27, 2021 04:11PM
Adamas Pharmaceuticals (ADMS) PT Lowered to $14 at JMP Securities Mar 4, 2021 11:00AM
Adamas Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares Mar 1, 2021 04:04PM
Adamas Pharma (ADMS) Prices 12.5M Share Follow-On Offering at $4.40/Sh Feb 25, 2021 08:18AM


Feb 24, 2021 09:16PM Adamas Pharmaceuticals Announces Pricing of Follow-on Public Offering
Feb 24, 2021 04:09PM Adamas Pharma (ADMS) Announces Launch of Follow-on Public Offering
Feb 24, 2021 04:08PM Adamas Pharmaceuticals Announces Launch of Follow-on Public Offering
Jul 8, 2020 07:25AM Companies with NDRs 7/08
Jun 3, 2019 04:31PM Adamas to Present at Upcoming JMP Investor Conference
Aug 25, 2017 06:46AM Adamas Pharmaceuticals (ADMS) PT Raised to $33 at JMP Securities Following GOCOVRI Approval and Strong Product Label
Jun 1, 2017 12:31PM Adamas to Present at Two Upcoming Investor Conferences
Apr 1, 2016 10:44AM Notable Analyst Rating Changes 4/1: (COF) (WING) (NFLX) Upgraded; (CMG) (SSW) (T) Downgraded
Apr 1, 2016 06:59AM JMP Securities Starts Adamas Pharmaceuticals (ADMS) at Market Outperform
Jan 6, 2016 10:37PM Adamas Pharma (ADMS) Prices 2.5M Shares at $23
Jan 6, 2016 10:08PM Adamas Announces Pricing of Public Offering of Common Stock
Jan 5, 2016 07:15AM Adamas Pharma (ADMS) Announces 2.5M Common Stock Offering
Jan 5, 2016 07:15AM Adamas Announces Proposed Public Offering of Common Stock
Jun 9, 2015 04:00PM Adamas Pharmaceuticals to Present at the 2015 JMP Securities Life Science Conference
Jun 9, 2015 04:00PM Adamas Pharmaceuticals to Present at the 2015 JMP Securities Life Science Conference